Following a minor acute SARS-CoV-2 infection, several health outcomes of patients who developed protracted COVID resolved one year later, according to a review of electronic medical records from an Israeli healthcare company.
According to Barak Mizrahi, MSc, a computational researcher at the KI Research Institute in Kfar Malal, Israel, and co-authors, the risk for the majority of outcomes appeared to decline between the early (30-180 days) and late (180-360 days) periods after infection.
Mizrahi and colleagues reported their findings in The BMJopens in a new tab or window.
After Math of COVID
“Our analysis revealed that of all the previously described symptoms and health outcomes, the risk of 13 outcomes was significantly higher in patients testing positive for SARS-CoV-2 compared with negative controls,” they wrote.
By mining data from a sizable health maintenance organization in Israel, the researchers looked for ICD-10 codes for roughly 70 health outcomes that might be connected to lengthy COVID. It continued for a year after infection, “Following these outcomes, shown with risk for several dropped, as compared to those who didn’t get infected.”
Words of Expert
Ziyad Al-Aly, MD, Chief of Research and Development at the Veterans Affairs St. Louis Health Care System and clinical epidemiologist at Washington University in St. Louis. He, who was not involved with the study, said, “I think we should interpret the study within the context of its design constraints.”
They continued for a year after infection, “following those outcomes, and showed that the risk for several of them dropped and was comparable with those without infection.”
By mining data from a sizable health maintenance organization in Israel, the researchers looked for ICD-10 codes for roughly 70 health outcomes that might be connected to lengthy COVID.
Read More News: Click Here